Sofinnova Investments

Sofinnova Investments, Inc. is a venture capital firm founded in 1974 and headquartered in Menlo Park, California, with additional offices in La Jolla, California, Montreal, Quebec, and Tokyo, Japan. The firm specializes in seed, early, and mid-stage investments, primarily focusing on the life sciences and information technology sectors. In life sciences, it targets clinical-stage pharmaceutical companies, biotechnology, and medical technologies addressing unmet medical needs, emphasizing areas such as oncology, neurology, and women’s health. For information technology, Sofinnova seeks product-oriented companies developing innovative software solutions and telecommunications infrastructure. The firm typically invests between $3 million and $15 million in technology companies and between $5 million and $30 million in life science companies, often requiring a board seat as part of its investment strategy. Sofinnova Investments emphasizes partnerships with entrepreneurs to help them build successful businesses and navigate key growth milestones, leveraging the expertise of its seasoned professionals.

Nathalie Auber

CFO and Partner

Eric Delbridge MD

Portfolio Manager and Partner, Public Equity

Jean Deleage

Co-Founder

Maha Katabi

General Partner

Jonathan Leff MD

Executive Partner, Private Equity

Naomi Pacalin

Analyst, Private Equity

Jason Pitts

Principal

Regina Salvat

Principal, Private Equity

Goro Takeda

Venture Partner

Mike Van

Associate, Private Equity

Harold Selnick Ph.D

Venture Partner

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.